Guardant Health Director Alex M. Azar II Sells Shares Under Rule 10b5-1 Plan

Insider Transaction Overview

On September 16, 2026, Guardant Health, Inc. ($GH) director Alex M. Azar II executed a sale of 826 shares of Common Stock at an average price of $175.00 per share, resulting in total transaction proceeds of approximately $144,550.

Transaction Details

• Reporting Owner: Alex M. Azar II
• Role: Director
• Security: Common Stock
• Transaction Code: S (Open market or private sale)
• Shares Sold: 826 shares
• Execution Price: $175.00
• Post-Transaction Holdings: 825 shares (Direct)
• Plan Details: The transaction was conducted pursuant to an affirmative defense conditions under Rule 10b5-1.

Significance Assessment

The transaction is categorized as Low significance. While the transaction represents roughly 50% of the insider's direct share count reported on this form, the absolute dollar value ($144,550) is modest for an institutional-scale issuer, and the sale was executed under a pre-established Rule 10b5-1 trading plan.